IAVI
Watch our latest IAVI Impact video to learn how IAVI's Lassa vaccine R&D model is changing the game.
IAVI Impact is a video series spotlighting how IAVI’s work is addressing urgent and unmet #glo
What is Sudan virus, and why do we need a vaccine to address this global health threat?
Hear directly from Swati Gupta, IAVI's VP and head of emerging infectious diseases and epidemiology.
Learn...
Scientists, health care professionals, communities, governments, funding agencies, and advocates are all coming together to work toward the same goal: a safe and effective HIV vaccine.
According ...
How was a global team able to launch a ring vaccination trial in just four days during an #Ebola outbreak?
On Jan. 30, Uganda confirmed its sixth disease outbreak due to Sudan virus (SUDV), an or...
“We will not go back.” That’s a wrap on #ias2025. Listen in for reflections and closing thoughts from Kigali.
After five full days of learning, exchange, and open conversations, the 13th Internati...
Tuberculosis (TB) caused 1.25 million deaths in 2023 despite existing treatment options.
A safe and effective vaccine would be a powerful tool to drive down TB infections, morbidity, and deaths ...
Adolescent girls and young women (AGYW) in sub-Saharan Africa continue to bear a disproportionate burden of the HIV epidemic, making up a significant portion of new infections. Despite advancements...
Wrap-up of AIDS 2024, with IAVI at the heart of global HIV/AIDS response dialogue
AIDS 2024, the 25th International AIDS Conference, concluded successfully in Munich, Germany, and virtually July...
The procedure of obtaining an ultrasound-guided fine needle aspiration of the axillary lymph nodes.
The procedure involves separating immune cells from blood for collection while returning the rest of the blood components to the blood donor. By using leukapheresis, scientists can collect enough w...
The procedure of obtaining an ultrasound-guided fine needle aspiration of the axillary lymph nodes.
The procedure involves separating immune cells from blood for collection while returning the rest of the blood components to the blood donor. By using leukapheresis, scientists can collect enough w...
We envision a world where all people have equitable access to innovative vaccines and therapeutics. At IAVI, we believe that biomedical innovation should be a global public good. Together, we’re cl...
Watch this video to learn more about VSV vaccines and how they work in the human body.
VSV is the same platform technology IAVI and our collaborators are using to develop vaccines for hemorrhagic...
Throughout 2022, IAVI continued to forge new and build on existing partnerships with governments, academia, industry, and other scientific consortia globally that advance vaccine and antibody candi...
The procedure involves separating immune cells from blood for collection while returning the rest of the blood components to the blood donor. By using leukapheresis, scientists can collect enough w...
The procedure of obtaining an ultrasound-guided fine needle aspiration of the axillary lymph nodes.
The procedure involves separating immune cells from blood for collection while returning the rest of the blood components to the blood donor. By using leukapheresis, scientists can collect enough w...
The procedure of obtaining an ultrasound-guided fine needle aspiration of the axillary lymph nodes.
Despite decades of progress in HIV prevention and treatment, millions are living with HIV as new infections continue around the world. Tools like PrEP are critical to slowing the spread of HIV, yet...